Drug Profile
Research programme: obesity gene therapy - Amsterdam Molecular Therapeutics BV/University of Barcelona
Latest Information Update: 16 Jul 2012
Price :
$50
*
At a glance
- Originator Amsterdam Molecular Therapeutics; University of Barcelona
- Class
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Obesity
Most Recent Events
- 17 Mar 2009 No development reported for Obesity in Netherlands (unspecified route)
- 19 Feb 2007 Early research in Obesity in Netherlands (unspecified route)